Yuval Cohen is the Chief Executive Officer of Corbus Pharmaceuticals, a company focused on developing novel anti-inflammatory drug programs.
Yuval Cohen is the Chief Executive Officer of Corbus Pharmaceuticals, a company focused on developing novel anti-inflammatory drug programs. He joined Corbus in July 2013 and previously co-founded and served as president of Celsus Therapeutics from 2005 to June 2013, where he successfully developed five anti-inflammatory drug programs. Cohen holds a Ph.D. from the Curie Institute of Cancer Research in Paris and the University of Paris V, and a Bachelor of Science (Honors) from the University of Cape Town.
Full founder directory · Investor directory · Company funding database · Fundraising library